Purpose: to evaluate the safety and tolerability of a potential new drug to treat neuroinflammation and the treatment of ALS.
Participate in a clinical study of a potential treatment for amyotrophic lateral sclerosis (ALS).
This study has 1 screening appointment and 8 outpatient visits and 1 follow up phone call.
Reimbursement for study participation will be provided for time and travel of up to $5,250
Dose Administration: daily liquid drink
This study has been reviewed by an Institutional Review Board.
Call 612-315-6490 to discuss your eligibility today!